Shares of MannKind (NASDAQ:MNKD) were downgraded to a Hold by stock research analysts at Maxim Group. With short interest at 26,337,802 and short average daily volume at 27,541,901, the short-interest ratio is 1.0 and the percentage of shorted shares is 0.23% as of October 13. Currently, 41.1% of the shares of the company are short sold.
In related news, Director Kent Kresa acquired 166,600 shares of MannKind Corporation stock in a transaction on Friday, October 13th. Finally, Zacks Investment Research downgraded shares of MannKind Corporation from a "hold" rating to a "sell" rating in a research report on Saturday, August 12th. As per Wednesday, November 1, the company rating was downgraded by Maxim Group. KCG Holdings Inc. grew its position in shares of MannKind Corporation by 268.0% in the 1st quarter. The stock remained 0.98% volatile for the week and 1.31% for the month. The stock has $115.59M outstanding shares. (NYSE:CHS) by 0.75% during the June 2017 quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Looking at a public company's insider trading can give great insight into how the stock is performing.
A number of institutional investors and hedge funds have recently modified their holdings of MNKD. MannKind Corporation earned a news impact score of 0.16 on Accern's scale.
However the company's price to cash per share for most recent quarter stands at 18.46.
(:) posting a after which it closed the day' session at $ and the company has experienced volume of shares while on average the company has a capacity of trading share while its relative trading volume is. MannKind Corporation's revenue was down 98.7% compared to the same quarter a year ago. MNKD stock price revealed optimistic move of 61.05% comparing average price of last 200 days.
MannKind Corporation (MNKD) opened at $3.21 on Tuesday. Bank of New York Mellon Corp now owns 108,380 shares of the biopharmaceutical company's stock valued at $236,000 after purchasing an additional 25,125 shares in the last quarter.
MannKind Corporation, (NASDAQ: MNKD) exhibits a change of -0.93% during last trading, with the company's shares hitting the price near $3.21 on active trading volume of 2571098 compared its three months average trading volume of 8.34M. The ATR may be used by market technicians to enter and exit trades, and it is a useful tool to add to a trading system. The stock's 52-week range is $0.67 to $6.96, and its 3-month range is $1.18 to $6.96.
MannKind Corporation (NASDAQ:MNKD) soared 0.83% year-to-date. Previously Mannkind Corporation (NASDAQ:MNKD) reported $-0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.2 by $-0.11 with surprise factor of -55%. The company had revenue of $2.04 million for the quarter, compared to analyst estimates of $2.56 million.
A statistical measure of the dispersion of returns (volatility) for GOOG producing salvation in Investors mouth, it has week volatility of 1.03% and for the month booked as 1.35%. A low number means that brokers and analysts expect that the industry outperform the market.
TRADEMARK VIOLATION WARNING: "Short Interest in MannKind Corporation (MNKD) Increases By 11.3%" was reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this news story on another site, it was illegally copied and republished in violation of global copyright law.
International Business Machines Corporation, a United States of America based Company, belongs to Technology sector and Information Technology Services industry. The Firm is focused on the discovery and development of therapeutic products for diseases, such as diabetes.